These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 935212)

  • 1. Blockade of the behavioral effects of 5-HTP by the decarboxylase inhibitor Ro 4-4602.
    Carter RB; Appel JB
    Pharmacol Biochem Behav; 1976 Apr; 4(4):407-9. PubMed ID: 935212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of peripheral mechanisms in the behavioral effects of 5-hydroxytryptophan.
    Carter RB; Dykstra LA; Leander JD; Appel JB
    Pharmacol Biochem Behav; 1978 Aug; 9(2):249-53. PubMed ID: 309609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a decarboxylase inhibitor (Ro 4-4602) on 5-HTP induced muricide blockade in rats.
    Bocknik SE; Kulkarni AS
    Neuropharmacology; 1974 Apr; 13(4):279-81. PubMed ID: 4546783
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the discriminative stimulus properties of l-5-hydroxytryptophan in the presence of either citalopram or Ro 4-4602.
    Winter JC; Rabin RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):613-6. PubMed ID: 3264918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of 5-HTp reduction of ethanol drinking with the decarboxylase inhibitor, ro 4-4602.
    Geller I; Hartmann RJ; Messiha FS
    Pharmacol Biochem Behav; 1981 Dec; 15(6):871-4. PubMed ID: 6976579
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that taste aversion learning induced by l-5-hydroxytryptophan is mediated peripherally.
    Ervin GN; Carter RB; Webster EL; Moore SI; Cooper BR
    Pharmacol Biochem Behav; 1984 May; 20(5):799-802. PubMed ID: 6610880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned taste aversion and conditioned drinking: two independent and opposing effects of 5-hydroxytryptophan?
    Willner P; Ellis T; Williams V; Chauvin P; Muscat R
    Psychopharmacology (Berl); 1986; 90(1):79-84. PubMed ID: 3094066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of L-5-hydroxytryptophan after destruction of ascending serotonergic pathways in the rat: the role of catecholaminergic neurons.
    Yunger LM; Harvey JA
    J Pharmacol Exp Ther; 1976 Feb; 196(2):307-15. PubMed ID: 1255478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human sleep and 5-HTP. Effects of repeated high doses and of association with benserazide (RO.04.4602).
    Autret A; Minz M; Bussel B; Cathala HP; Castaigne P
    Electroencephalogr Clin Neurophysiol; 1976 Oct; 41(4):408-13. PubMed ID: 60227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of firing of raphe neurones by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro-4-4602.
    Gallager DW; Aghajanian GK
    Neuropharmacology; 1976 Mar; 15(3):149-56. PubMed ID: 1084488
    [No Abstract]   [Full Text] [Related]  

  • 12. Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitor.
    Doller HJ; Connor JD; Lock DR; Sloviter RS; Dvorchik BH; Vesell ES
    Drug Metab Dispos; 1978; 6(2):164-8. PubMed ID: 26532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of benserazide (Ro4-4602) on the concentration of indoleamines in rat pineal and hypothalamus.
    Arendt J; Ho AK; Laud C; Marston A; Nohria V; Smith JA; Symons AM
    Br J Pharmacol; 1981 Feb; 72(2):257-62. PubMed ID: 7214095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a decarboxylase inhibitor, benserazide, on both thermoregulation and chlorpromazine-induced hypothermia in rats.
    Lin MT; Chow CF; Chern YF
    J Pharm Pharmacol; 1978 Dec; 30(12):759-61. PubMed ID: 32239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
    Hyttel J; Fjalland B
    Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
    [No Abstract]   [Full Text] [Related]  

  • 18. Tryptophan-induced suppression of conditioned avoidance behavior in rats.
    Engel J; Modigh K
    Adv Biochem Psychopharmacol; 1974; 11(0):405-9. PubMed ID: 4845707
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of L-tryptophan on motor activity and its prevention by an extracerebral decarboxylase inhibitor and by 5-HT receptor blockers.
    Tricklebank MD; Drewitt PN; Curzon G
    Psychopharmacology (Berl); 1980; 69(2):173-7. PubMed ID: 6779309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tetrahydropapaveroline with inhibition of dopa-decarboxylase by Ro 4-4602 in brain: effects on alcohol drinking in the rat.
    Miñano FJ; McMillen BA; Myers RD
    Alcohol; 1989; 6(2):133-7. PubMed ID: 2713086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.